Cordant »

Crispr Therapeutics shares owned by Cordant

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Cordant from 13F filings

Historical chart of Cordant investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Cordant consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Cordant

Quarter filed Position value Share count Share price at filing
2026-06-30 $546 10 54.60
2025-03-31 $3.9k 114 34.04

More positions owned by Cordant

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Index Fds Real Estate Etf (VNQ)
Invesco Db Commdy Indx Trck Unit (DBC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Us Larg Valu Etf (DFLV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Dimensional Etf Trust Intl Vec Equ Etf (DXIV)
Dimensional Etf Trust Internatnal Val (DFIV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Cordant

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics